5-N-Acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners.
Jill E. Hochlowski(Abbott (United Kingdom)), MARK M. MULLALLY(Abbott (United Kingdom)), Stephen G. Spanton(Abbott (United Kingdom)), David N. Whittern(Abbott (United Kingdom)), PRESTON HILL(Abbott (United Kingdom)), James B. McAlpine(Abbott (United Kingdom))
Cited by 101Open Access
Abstract
A family of novel compounds has been detected and isolated following an assay for the attenuation of multiple drug resistance in tumor cells from the fermentation broth and mycelia of a strain of Aspergillus fischeri which we have designated var. brasiliensis. The structures of three components were determined employing 1-D and 2-D homonuclear and heteronuclear NMR spectroscopy and mass spectrometry. The structure of 5-N-acetylardeemin was confirmed by single crystal X-ray diffraction. These compounds are most closely structurally related to asperlicin E1).
Related Papers
No related papers found
Powered by citation graph analysis